If you think last week's decision by the federal government to halt $500 million in funding for vaccine development projects that use mRNA technology will only affect COVID vaccines, think again.
Pharmaceutical Technology on MSN
BioNTech co-founders step down to launch new mRNA venture
The leadership changes arrive as BioNTech reported a 57% rise in net losses for 2025.
The world could be only a few years away from a cancer vaccine, according to the couple behind the Pfizer/BioNtech COVID-19 vaccine. "We feel that a cure for cancer or to changing cancer patients' ...
European regulators have approved Moderna Inc.’s novel combination flu and Covid shot, handing a victory to the embattled ...
The administration had cut crucial funding for mRNA-based therapies. The rest of the world might step in and benefit.
Health and Human Services Secretary Robert F. Kennedy Jr. revealed his agency will be cutting funding to mRNA development, calling the vaccine technology "ineffective" and claiming it poses more risks ...
Add Yahoo as a preferred source to see more of our stories on Google. The United States is turning its back on what could be the greatest medical advance in a generation — vaccines made with messenger ...
The Food and Drug Administration is refusing to consider Moderna's application for a new flu vaccine made with mRNA technology, the company said.
Read more about Future pandemics may be fought faster with mRNA and advanced vaccine platforms on Devdiscourse ...
Vials of the Pfizer-BioNTech COVID-19 vaccine are shown in 2023. It was formulated using mRNA technology. Lee S. Weissman USA TODAY NETWORK As a longtime pediatrician in South Carolina, I am deeply ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results